AVAHAveanna Healthcare Holdings Inc.

$13.38+34% 1Y

Is the price fair?

Good

Cheap vs its sector. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data
Vs sector (EV/EBIT)15.0×derived · Jul 4, 2026

Sector median 25.1× across 135 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)better than 89% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What AVAH's price assumes

Aveanna Healthcare Holdings Inc. trades at 10.6× earnings against 20.2× for the median Medical Care Facilities name, cheaper than its own group.

10.6

Trailing P/E · Medical Care Facilities median 20.2 · cheaper than the typical name in its group

Price / sales
1.12

Price / sales · today's price, trailing year to Jul 4, 2026

Price / book
10.2

Price / book · today's price, trailing year to Jul 4, 2026

EV / sales
1.58

EV / sales

Details›
Price / booktoday's price, trailing year to Jul 4, 2026
10.2
EV / EBITtoday's price, trailing year to Jul 4, 2026
15.0
EV / salestoday's price, trailing year to Jul 4, 2026
1.58
Healthcare median P/E503 names
27.9
Medical Care Facilities median P/E32 names
20.2
Market capitalisation218.2 million shares, counted Aug 7, 2026
$2.92B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.